Analysis of the impact of CSPG4 expression levels as a prognostic factor showed neither a significant effect on OS (Figure 5a; p = 0.161) nor on the EFS (Figure 5b; p = 0.204) of the pediatric AML patients. The gene discussed is CSPG4; the disease is acute myeloid leukemia.